Alaethes Wealth’s Microbot Medical MBOT Stock Holding History

Alaethes Wealth’s Portfolio MBOT Stock Details MBOT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-1	Closed	–	–	223
2022 Q1	$0	Hold	1	–	–	﹤0.01%	315
2021 Q4	$0	Hold	1	–	–	﹤0.01%	290
2021 Q3	$0	Hold	1	–	–	﹤0.01%	280
2021 Q2	$0	Buy	+1	New	+$8	﹤0.01%	265

Other funds holding MBOT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

CAN

Cetera Advisor Networks El Segundo, California $20.2B AUM 22.31% 1-Year Est. Return

SPIA

Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Alaethes Wealth's MBOT Position: Q2 2022 in Review

Alaethes Wealth sold out of Microbot Medical (MBOT) in Q2 2022, closing a stake of 1 share.

Alaethes Wealth first reported a position in MBOT in Q2 2021 and held it in 4 quarters. The position peaked at $0 in Q1 2022. 25 funds tracked by Wall St. Rank hold MBOT as of Q2 2022.

Alaethes Wealth reported no remaining Microbot Medical position as of Q2 2022 after selling out during the quarter.
Alaethes Wealth sold 1 Microbot Medical share in Q2 2022.
Alaethes Wealth first reported a position in Microbot Medical in Q2 2021 and held it in 4 quarters.
Alaethes Wealth's Microbot Medical position peaked at $0 in Q1 2022.
25 funds tracked by Wall St. Rank held Microbot Medical as of Q2 2022.

Based on Alaethes Wealth's 13F filing for Q2 2022, filed 16 Aug 2022.